Inovio unit gets approval in South Korea to test avian flu vaccine

03/2/2010 | American City Business Journals

Inovio Biomedical said regulators in South Korea granted its affiliate, VGX International, approval to begin a first-stage trial of an experimental DNA vaccine against H5N1 flu. Inovio said it plans to start testing the vaccine in the U.S. later this year as it works on a DNA-based universal flu vaccine.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN